Xiaozhen Cao

Southwest Hospital

Papers

1

Total Citations

50

H-Index

1

About

Xiaozhen Cao is a leading surgical oncologist whose research focuses on advancing breast cancer treatment through minimally invasive techniques. Her most impactful work investigates the long-term oncologic outcomes of minimal access breast surgery (MABS) compared to conventional breast surgery (CBS). In her landmark 2022 study, cited over 50 times, Cao provided critical evidence that MABS can achieve comparable long-term prognostic results to traditional approaches, addressing a key gap in the literature that had previously limited the adoption of these less invasive procedures. By systematically analyzing therapeutic outcomes, she has helped validate MABS as a safe and effective option for breast cancer management, potentially improving patient recovery and quality of life without compromising oncologic safety. Her contributions are particularly significant for surgeons seeking to balance cosmetic preservation with rigorous cancer control. Cao’s work continues to shape clinical guidelines and inspire further research into optimizing surgical approaches for breast cancer patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
50
Total Citations
50
Avg Citations/Paper
🏆 Most Cited Paper
Association of Long-term Oncologic Prognosis With Minimal Access Breast Surgery vs Conventional Breast Surgery
50 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Southwest Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago